Prostate volume changes during permanent seed brachytherapy: An analysis of intra-operative variations, predictive factors and clinical implication

Radiation Oncology

Volumn 8, Issue 1, 2013, Pages

  Chira, Ciprian ^a,b   Delouya, Guila ^a,b   Larrivée, Sandra ^b   Carrier, Jean Francois ^a,b   Taussky, Daniel ^a,b  

^a NOTRE DAME HOSPITAL   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Intra operative edema; Permanent seed brachytherapy; Prostate

Indexed keywords

IODINE 125; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; BRACHYTHERAPY IMPLANT; CANCER GROWTH; CANCER STAGING; GLEASON SCORE; HUMAN; INTRAOPERATIVE PERIOD; MALE; PROSTATE CARCINOMA; PROSTATE VOLUME; TRANSRECTAL ULTRASONOGRAPHY; URINE RETENTION;

ADENOCARCINOMA; AGED; BRACHYTHERAPY; EDEMA; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PROSTATE; PROSTATIC NEOPLASMS; RADIOMETRY; RADIOTHERAPY DOSAGE; URINARY RETENTION;

EID: 84880017387     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-8-177     Document Type: Article

References (22)

1. Dogan N, Mohideen N, Glasgow GP, Keys K, Flanigan RC. Effect of prostatic edema on CT-based postimplant dosimetry. Int J Radiat Oncol Biol Phys 2002, 53:483-489. 10.1016/S0360-3016(02)02762-1, 12023153.
2. Chen ZJ, Roberts K, Decker R, Pathare P, Rockwell S, Nath R. The impact of prostate edema on cell survival and tumor control after permanent interstitial brachytherapy for early stage prostate cancers. Phys Med Biol 2011, 56:4895-4912. 10.1088/0031-9155/56/15/016, 3154133, 21772076.
3. Bucci J, Morris WJ, Keyes M, Spadinger I, Sidhu S, Moravan V. Predictive factors of urinary retention following prostate brachytherapy. Int J Radiat Oncol Biol Phys 2002, 53:91-98. 10.1016/S0360-3016(01)02812-7, 12007946.
4. Ohashi T, Yorozu A, Toya K, Saito S, Momma T, Nagata H, Kosugi M, Shigematsu N, Kubo A. Comparison of intraoperative ultrasound with postimplant computed tomography-dosimetric values at Day 1 and Day 30 after prostate brachytherapy. Brachytherapy 2007, 6:246-253. 10.1016/j.brachy.2007.08.006, 17959425.
5. Solhjem MC, Davis BJ, Pisansky TM, Wilson TM, Mynderse LA, Herman MG, King BF, Geyer SM. Prostate volume measurement by transrectal ultrasound and computed tomography before and after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 2004, 60:767-776. 10.1016/j.ijrobp.2004.04.015, 15465193.
6. Speight JL, Shinohara K, Pickett B, Weinberg VK, Hsu IC, Roach M. Prostate volume change after radioactive seed implantation: possible benefit of improved dose volume histogram with perioperative steroid. Int J Radiat Oncol Biol Phys 2000, 48:1461-1467. 10.1016/S0360-3016(00)00798-7, 11121649.
7. Zilli T, Taussky D, Donath D, Le HP, Larouche R-X, Béliveau-Nadeau D, Hervieux Y, Delouya G. Urethra-sparing, intraoperative, real-time planned, permanent-seed prostate brachytherapy: toxicity analysis. Int J Radiat Oncol Biol Phys 2011, 81:e377-383. 10.1016/j.ijrobp.2011.02.037, 21514068.
8. Tanaka O, Hayashi S, Matsuo M, Nakano M, Uno H, Ohtakara K, Miyoshi T, Deguchi T, Hoshi H. Effect of edema on postimplant dosimetry in prostate brachytherapy using CT/MRI fusion. Int J Radiat Oncol Biol Phys 2007, 69:614-618. 10.1016/j.ijrobp.2007.05.082, 17869675.
9. Sloboda RS, Usmani N, Pedersen J, Murtha A, Pervez N, Yee D. Time course of prostatic edema post permanent seed implant determined by magnetic resonance imaging. Brachytherapy 2010, 9:354-361. 10.1016/j.brachy.2009.09.008, 20116344.
10. Liu D, Usmani N, Ghosh S, Kamal W, Pedersen J, Pervez N, Yee D, Danielson B, Murtha A, Amanie J, Sloboda RS. Comparison of prostate volume, shape, and contouring variability determined from preimplant magnetic resonance and transrectal ultrasound images. Brachytherapy 2012, 11:284-291. 10.1016/j.brachy.2011.11.004, 22197014.
11. Martinez AA, Pataki I, Edmundson G, Sebastian E, Brabbins D, Gustafson G. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report. Int J Radiat Oncol Biol Phys 2001, 49:61-69. 10.1016/S0360-3016(00)01463-2, 11163498.
12. Smith RP, Beriwal S, Komanduri K, Gibbons E, Benoit R. Planning based on postneedle volume with early dosimetric assessment is beneficial for Cesium-131 permanent prostate seed implantation. Brachytherapy 2008, 7:237-241. 10.1016/j.brachy.2008.04.003, 18599357.
13. Chung E, Stenmark MH, Evans C, Narayana V, McLaughlin PW. Greater postimplant swelling in small-volume prostate glands: implications for dosimetry, treatment planning, and operating room technique. Int J Radiat Oncol Biol Phys 2012, 82:1944-1948. 10.1016/j.ijrobp.2011.03.024, 21640498.
14. Taussky D, Austen L, Toi A, Yeung I, Williams T, Pearson S, McLean M, Pond G, Crook J. Sequential evaluation of prostate edema after permanent seed prostate brachytherapy using CT-MRI fusion. Int J Radiat Oncol Biol Phys 2005, 62:974-980. 10.1016/j.ijrobp.2004.12.012, 15989997.
15. Stock RG, Stone NN, Dahlal M, Lo YC. What is the optimal dose for 125I prostate implants? A dose-response analysis of biochemical control, posttreatment prostate biopsies, and long-term urinary symptoms. Brachytherapy 2002, 1:83-89. 10.1016/S1538-4721(02)00017-X, 15062175.
16. Potters L, Cao Y, Calugaru E, Torre T, Fearn P, Wang XH. A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 2001, 50:605-614. 10.1016/S0360-3016(01)01473-0, 11395226.
17. Zelefsky MJ, Kuban DA, Levy LB, Potters L, Beyer DC, Blasko JC, Moran BJ, Ciezki JP, Zietman AL, Pisansky TM, Elshaikh M, Horwitz EM. Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. Int J Radiat Oncol Biol Phys 2007, 67:327-333. 10.1016/j.ijrobp.2006.08.056, 17084558.
18. Terk MD, Stock RG, Stone NN. Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate. J Urol 1998, 160:1379-1382. 10.1016/S0022-5347(01)62542-4, 9751358.
19. Locke J, Ellis W, Wallner K, Cavanagh W, Blasko J. Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: a prospective study. Int J Radiat Oncol Biol Phys 2002, 52:712-719. 10.1016/S0360-3016(01)02657-8, 11849794.
20. Crook J, McLean M, Catton C, Yeung I, Tsihlias J, Pintilie M. Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation. Int J Radiat Oncol Biol Phys 2002, 52:453-460. 10.1016/S0360-3016(01)02658-X, 11872292.
21. Feigenberg SJ, Wolk KL, Yang C-H, Morris CG, Zlotecki RA. Celecoxib to decrease urinary retention associated with prostate brachytherapy. Brachytherapy 2003, 2:103-107. 10.1016/S1538-4721(03)00100-4, 15062148.
22. Sacco DE, Daller M, Grocela JA, Babayan RK, Zietman AL. Corticosteroid use after prostate brachytherapy reduces the risk of acute urinary retention. BJU Int 2003, 91:345-349. 10.1046/j.1464-410X.2003.04082.x, 12603412.